Fraison, E., Kostova, E., Moran, L. J., Bilal, S., Ee, C. C., Venetis, C., & Costello, M. F. (2020). Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database of Systematic Reviews, 8(8), CD005552. https://doi.org/10.1002/14651858.CD005552.pub3
Alesi, S., Forslund, M., Melin, J., Romualdi, D., Peña, A., Tay, C. T., Witchel, S. F., Teede, H., & Mousa, A. (2023). Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine, 63, 102162. https://doi.org/10.1016/j.eclinm.2023.102162
Noachtar, I. A., Frokjaer, V. G., & Pletzer, B. (2023). Mental Health Symptoms in Oral Contraceptive Users During Short-Term Hormone Withdrawal. JAMA Network Open, 6(9), e2335957. https://doi.org/10.1001/jamanetworkopen.2023.35957
de Medeiros, S. F. (2017). Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome. Reproductive Biology and Endocrinology RB&E, 15(1), 93. https://doi.org/10.1186/s12958-017-0313-y
Wolff, H., Fischer, T. W., & Blume-Peytavi, U. (2016). The Diagnosis and Treatment of Hair and Scalp Diseases. Deutsches Arzteblatt International, 113(21), 377-386. https://doi.org/10.3238/arztebl.2016.0377
Treister-Goltzman, Y., Yarza, S., & Peleg, R. (2022). Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-Analysis. Skin Appendage Disorders, 8(2), 83-92. https://doi.org/10.1159/000519952
Aguilar Medina, D. A., Cazarín, J., & Magaña, M. (2022). Spironolactone in dermatology. Dermatologic Therapy, 35(5), e15321. https://doi.org/10.1111/dth.15321
Ntshingila, S., Oputu, O., Arowolo, A. T., & Khumalo, N. P. (2023). Androgenetic alopecia: An update. JAAD International, 13, 150-158. https://doi.org/10.1016/j.jdin.2023.07.005